Pharmafile Logo
Pharmafocus logo
Advanced Search

Q3

Showing 9 posts of 24 posts found.

gsk image

GSK hit by European austerity again

November 1, 2012
Sales and Marketing Europe, GSK, Q3, austerity

GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …

News
Astrazeneca image

Sharp fall for AstraZeneca

October 26, 2012
Sales and Marketing AstraZeneca, Brennan, Q3, Soriot

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

News
J&J image

J&J profits down in Q3

October 17, 2012
Sales and Marketing J&J, JJ, Johnson & Johnson, Q3, Risperdal

Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …

News

The changing of the guard – Q3 round up

November 25, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …

Feature
Lonza image

Lonza sees continued recovery in third quarter

November 1, 2011
Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production

Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …

News
GSK logo

GSK sees strong Q3 after battling headwinds

October 27, 2011
Business Services, Sales and Marketing GSK, GSK. Q3, Q3

GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …

News
AstraZeneca

Patent expiries bite into AstraZeneca revenues

October 29, 2010
Sales and Marketing AstraZeneca, Crestor, Q3, Seroquel

Generic competition and a major drop off in pandemic influenza products saw AstraZeneca’s revenue fall for the third quarter. Revenue …

News

Novartis posts strong Q3 results

October 21, 2010
Sales and Marketing 2010 financials, Novartis, Novartis quarterly results, Q3, pharma sales

Novartis has posted double digit growth for the third quarter following a strong showing by a number of recently launched …

News
Swiss pharma company Roche

Roche revenue depressed by plummeting Tamiflu sales

October 15, 2010
Sales and Marketing 2010 financials, Q3, Roche

Roche suffered a 3% drop in group revenue in the third quarter as sales of its Tamiflu plummeted by 90 …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025